Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer

NCT00544765 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2014
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

GBG Forschungs GmbH

Collaborators